Kestra Medical insider plans stock sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Kestra Medical Technologies, Ltd. has a planned sale of 6,995 shares of common stock through Merrill Lynch on NASDAQ on 08/04/2026. These shares relate to the 07/17/2026 vesting of performance share unit awards granted under the issuer’s equity compensation plan.
The filing also lists prior sales by Vaseem Mahboob over the past three months: 3,980 shares on 07/30/2026 for 90,560.62, 8,817 shares on 07/31/2026 for 199,344.62, and 5,391 shares on 08/03/2026 for 128,312.27.
Key Figures
Key Terms
equity compensation plan financial
Securities Sold During The Past 3 Months regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stock sale is disclosed for KMTS in this Form 144?
Who is the selling security holder in the KMTS Form 144?
What total values are reported for recent KMTS stock sales by Vaseem Mahboob?
AI-generated analysis. How Rhea-AI works. Not financial advice.